Fol. Biol. 2014, 60, 28-34
https://doi.org/10.14712/fb2014060010028
Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy
References
1. , E. L., Hershberger, R. E. (2005) Clinical and genetic issues in familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 45, 969-981.
<https://doi.org/10.1016/j.jacc.2004.11.066>
2. , P., Carrier, L., Dubourg, O., Tesson, F., Desnos, M., Richard, P., Bonne, G., Guicheney, P., Hainque, B., Bouhour, J. B., Mallet, A., Feingold, J., Schwartz, K., Komajda, M. (1997) Penetrance of familial hypertrophic cardiomyopathy. Genet. Couns. 8, 107-114.
3. , P., Dubourg, O., Desnos, M., Bennaceur, M., Carrier, L., Camproux, A. C., Isnard, R., Hagege, A., Langlard, J. M., Bonne, G., Richard, P., Hainque, B., Bouhour, J. B., Schwartz, K., Komajda, M. (1998) Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 97, 2230-2236.
<https://doi.org/10.1161/01.CIR.97.22.2230>
4. , P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., Helio, T., Keren, A., McKenna, W. J., Monserrat, L., Pankuweit, S., Perrot, A., Rapezzi, C., Ristic, A., Seggewiss, H., van Langen, I., Tavazzi, L. (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 31, 2715-2728.
<https://doi.org/10.1093/eurheartj/ehq271>
5. , P. P., Bober, M., Michałowska, J., Sorysz, D. (2009) Left ventricular outflow tract gradient provoked by upright position or exercise in treated patients with hypertrophic cardiomyopathy without obstruction at rest. Echocardiography 26, 513-520.
<https://doi.org/10.1111/j.1540-8175.2008.00851.x>
6. , F., Vecoli, C., Foffa, I., Andreassi, M. G. (2012) Next generation sequencing in cardiovascular diseases. World J. Cardiol. 4, 288-295.
<https://doi.org/10.4330/wjc.v4.i10.288>
7. , E., Gackowski, A., du Montcel, S. T., Isnard, R., Hamroun, A., Richard, P., Komajda, M., Charron, P. (2010) Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler paging. Eur. Heart J. 31, 1599-1607.
<https://doi.org/10.1093/eurheartj/ehq101>
8. , B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., Seidman, C. E., Towbin, J. A., Udelson, J. E., Yancy, C. W.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 124, 783-831.
9. , C. Y., Sweitzer, N. K., McDonough, B., Maron, B. J., Casey, S. A., Seidman, J. G., Seidman, C. E., Solomon, S. D. (2002) Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105, 2992-2997.
<https://doi.org/10.1161/01.CIR.0000019070.70491.6D>
10. , S. J., Iizuka, K., Kelly, R. A., Geng, Y. J., Bishop, S. P., Yang, G., Kudej, A., McConnell, B. K., Seidman, C. E., Seidman, J. G., Vatner, S. F. (1999) An α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes. Am. J. Physiol. 276, 1780-1787.
11. , R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., Solomon, S. D., Spencer, K. T., Sutton, M. S., Stewart, W. J.; Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440-1463.
<https://doi.org/10.1016/j.echo.2005.10.005>
12. , A. J., Roberts, R. (1994) Molecular basis of hypertrophic and dilated cardiomyopathy. Tex. Heart Inst. J. 21, 6-15.
13. , A. J., Zhao, G., Seta, Y., Roberts, R., Yu, Q. T. (1997) Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ. Res. 81, 76-85.
<https://doi.org/10.1161/01.RES.81.1.76>
14. , A. J. (2000) Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 355, 58-60.
<https://doi.org/10.1016/S0140-6736(99)06187-5>
15. , B. J., Niimura, H., Casey, S. A., Soper, M. K., Wright, G. B., Seidman, J. G., Seidman, C. E. (2001) Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J. Am. Coll. Cardiol. 38, 315-321.
<https://doi.org/10.1016/S0735-1097(01)01386-9>
16. , B. J., Maron, M. S. (2013) Hypertrophic cardiomyopathy. Lancet 381, 242-255.
<https://doi.org/10.1016/S0140-6736(12)60397-3>
17. , M., Soliman, O. I., Kofflard, M. J., Hoedemaekers, Y. M., Dooijes, D., Majoor-Krakauer, D., ten Cate, F. J. (2009) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc. Imaging 2, 58-64.
<https://doi.org/10.1016/j.jcmg.2008.08.003>
18. , H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H., Chudley, A. E., McKenna, W., Kristinsson, A., Roberts, R., Sole, M., Maron, B. J., Seidman, J. G., Seidman, C. E. (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338, 1248-1257.
<https://doi.org/10.1056/NEJM199804303381802>
19. , T., Tesarova, M., Kuchynka, P., Dytrych, V., Elleder, M., Hulkova, H., Hansikova, H., Honzik, T., Zeman, J., Linhart, A. (2012) Hypertrophic cardiomyopathy due to the mitochondrial DNA mutation m.3303C>T diagnosed in an adult male. Int. Heart J. 53, 383-387.
<https://doi.org/10.1536/ihj.53.383>
20. , A. M., Elliott, P. M., Baboonian, C., Davison, F., Davies, M. J., McKenna, W. J. (2001) Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 104, 1380-1384.
<https://doi.org/10.1161/hc3701.095952>
21. , H., Thierfelder, L., Hwang, D. S., McKenna, W., Seidman, J. G., Seidman, C. E. (1992) Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J. Clin. Invest. 90, 1666-1671.
<https://doi.org/10.1172/JCI116038>
22. , H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O’Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G (1995) Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332, 1058-1064.
<https://doi.org/10.1056/NEJM199504203321603>
23. , D., Tomasov, P., Homolova, S., Linhartova, K., Veselka, J. (2011) Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy. Eur. J. Echocardiogr. 12, 684-687.
<https://doi.org/10.1093/ejechocard/jer115>
